Published in Cancer Res on February 09, 2010
Understanding cancer stem cell heterogeneity and plasticity. Cell Res (2012) 2.39
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci U S A (2013) 2.25
Cancer stem cells in glioblastoma. Genes Dev (2015) 1.91
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro Oncol (2011) 1.80
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev (2012) 1.64
Current strategies for identification of glioma stem cells: adequate or unsatisfactory? J Oncol (2012) 1.40
An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep (2013) 1.35
CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J (2011) 1.32
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci U S A (2011) 1.30
Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment. Clin Dev Immunol (2011) 1.24
CD133: a stem cell biomarker and beyond. Exp Hematol Oncol (2013) 1.24
Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. Neoplasia (2012) 1.22
Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival. Genome Med (2012) 1.11
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma. Cancer Immunol Immunother (2013) 1.08
Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival. Clin Cancer Res (2012) 1.03
Cancer stem cell contribution to glioblastoma invasiveness. Stem Cell Res Ther (2013) 0.98
From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity. Oncotarget (2015) 0.96
The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells Dev (2012) 0.95
Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms. J Cell Mol Med (2013) 0.95
Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape? Front Immunol (2014) 0.93
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Oncotarget (2015) 0.93
Multi-kinase inhibitor C1 triggers mitotic catastrophe of glioma stem cells mainly through MELK kinase inhibition. PLoS One (2014) 0.93
Snail depletes the tumorigenic potential of glioblastoma. Oncogene (2013) 0.93
Seeing is believing: are cancer stem cells the Loch Ness monster of tumor biology? Stem Cell Rev (2011) 0.92
The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence. Neuro Oncol (2013) 0.92
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells. Neuro Oncol (2013) 0.91
A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells. PLoS One (2012) 0.91
Cancer stem cells: constantly evolving and functionally heterogeneous therapeutic targets. Cancer Res (2014) 0.91
Metastatic cancer stem cells: from the concept to therapeutics. Am J Stem Cells (2014) 0.89
CD133(+) single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential. Clin Exp Metastasis (2010) 0.89
Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme. Oncotarget (2015) 0.87
Glioblastoma stem cells: Molecular characteristics and therapeutic implications. World J Stem Cells (2014) 0.86
Insights into Chemoresistance of Prostate Cancer. Int J Biol Sci (2015) 0.86
A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1. PLoS One (2013) 0.86
Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells. BMC Cancer (2012) 0.86
Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines. PLoS One (2013) 0.85
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets. Stem Cells Int (2016) 0.85
Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells. Oncotarget (2016) 0.84
The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities. Neuro Oncol (2015) 0.84
RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation. Oncotarget (2014) 0.83
Identification of CD133(-)/telomerase(low) progenitor cells in glioblastoma-derived cancer stem cell lines. Cell Mol Neurobiol (2010) 0.83
Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis. PLoS One (2013) 0.83
Targeted therapy against cancer stem cells. Oncol Lett (2015) 0.82
Contemporary murine models in preclinical astrocytoma drug development. Neuro Oncol (2014) 0.81
Development of robust discriminant equations for assessing subtypes of glioblastoma biopsies. Br J Cancer (2012) 0.81
Dissecting the Origin of Breast Cancer Subtype Stem Cell and the Potential Mechanism of Malignant Transformation. PLoS One (2016) 0.80
Therapeutic approaches to target cancer stem cells. Cancers (Basel) (2011) 0.80
Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency. Oncogene (2016) 0.79
Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma. Cancer Cell Int (2013) 0.79
Mesenchymal stem cell-like properties of CD133+ glioblastoma initiating cells. Oncotarget (2016) 0.79
Hypothermia stimulates glioma stem spheres to spontaneously dedifferentiate adjacent non-stem glioma cells. Cell Mol Neurobiol (2014) 0.78
Identification of U251 glioma stem cells and their heterogeneous stem-like phenotypes. Oncol Lett (2013) 0.78
ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis. J Natl Cancer Inst (2015) 0.78
Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells. PLoS One (2015) 0.78
The potential origin of glioblastoma initiating cells. Front Biosci (Schol Ed) (2012) 0.78
Biological and clinical implications of cancer stem cells in primary brain tumors. Front Oncol (2013) 0.78
Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells. Glia (2014) 0.78
Presence of glioma stroma mesenchymal stem cells in a murine orthotopic glioma model. Childs Nerv Syst (2011) 0.77
Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells. Cancer Res (2015) 0.77
A Prominin-1-Rich Pediatric Glioblastoma: Biologic Behavior Is Determined by Oxygen Tension-Modulated CD133 Expression but Not Accompanied by Underlying Molecular Profiles. Transl Oncol (2012) 0.77
Perivascular Mesenchymal Stem Cells From the Adult Human Brain Harbor No Instrinsic Neuroectodermal but High Mesodermal Differentiation Potential. Stem Cells Transl Med (2015) 0.76
TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme. Stem Cells (2016) 0.76
Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties. Mol Cell Proteomics (2015) 0.76
Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations. BMC Cancer (2016) 0.75
Overcoming therapeutic resistance in glioblastoma: the way forward. J Clin Invest (2017) 0.75
Mesenchymal stem cells: A new diagnostic tool? World J Stem Cells (2015) 0.75
Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells. Stem Cells Int (2016) 0.75
Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity. PLoS One (2017) 0.75
A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nat Commun (2016) 0.75
Label-retaining assay enriches tumor-initiating cells in glioblastoma spheres cultivated in serum-free medium. Oncol Lett (2016) 0.75
CDK4/6 inhibition is more active against the glioblastoma proneural subtype. Oncotarget (2017) 0.75
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med (2006) 7.42
Neuroplasticity: changes in grey matter induced by training. Nature (2004) 7.35
Estimating amino acid substitution models: a comparison of Dayhoff's estimator, the resolvent approach and a maximum likelihood method. Mol Biol Evol (2002) 7.03
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 6.21
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science (2004) 5.94
Dissecting the architecture of a quantitative trait locus in yeast. Nature (2002) 5.24
Systematic screen for human disease genes in yeast. Nat Genet (2002) 4.97
The extent of linkage disequilibrium in Arabidopsis thaliana. Nat Genet (2002) 4.96
Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem (2003) 4.72
The role of selection in the evolution of human mitochondrial genomes. Genetics (2005) 4.56
Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell (2012) 4.28
Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci (2005) 3.79
A back migration from Asia to sub-Saharan Africa is supported by high-resolution analysis of human Y-chromosome haplotypes. Am J Hum Genet (2002) 3.71
A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell (2009) 3.63
Genome sequencing and comparative analysis of Saccharomyces cerevisiae strain YJM789. Proc Natl Acad Sci U S A (2007) 3.52
Inferring cellular networks--a review. BMC Bioinformatics (2007) 3.49
Origin, diffusion, and differentiation of Y-chromosome haplogroups E and J: inferences on the neolithization of Europe and later migratory events in the Mediterranean area. Am J Hum Genet (2004) 3.28
Excavating Y-chromosome haplotype strata in Anatolia. Hum Genet (2003) 3.15
Neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics (2010) 2.98
Melanesian and Asian origins of Polynesians: mtDNA and Y chromosome gradients across the Pacific. Mol Biol Evol (2006) 2.98
Part 15: neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 2.85
Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res (2008) 2.84
Strategies for implementing screening for critical congenital heart disease. Pediatrics (2011) 2.72
Analysis of microtubule dynamic instability using a plus-end growth marker. Nat Methods (2010) 2.67
Hemodynamic changes in preterm neonates with septic shock: a prospective observational study*. Pediatr Crit Care Med (2014) 2.65
Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res (2007) 2.62
RGS9 modulates dopamine signaling in the basal ganglia. Neuron (2003) 2.61
T cells become licensed in the lung to enter the central nervous system. Nature (2012) 2.45
Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol (2006) 2.38
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res (2004) 2.35
Phylogeography of Y-chromosome haplogroup I reveals distinct domains of prehistoric gene flow in europe. Am J Hum Genet (2004) 2.32
Integrative analysis of the mitochondrial proteome in yeast. PLoS Biol (2004) 2.31
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions. Dtsch Arztebl Int (2010) 2.27
Planning the human variome project: the Spain report. Hum Mutat (2009) 2.22
Construction of bridged and fused ring systems via intramolecular Michael reactions of vinylnitroso compounds. J Am Chem Soc (2007) 2.19
A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr (2005) 2.12
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem (2006) 2.08
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet (2012) 2.07
Off-label use of drugs in neonatal intensive care units. Indian Pediatr (2014) 2.03
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet (2009) 2.02
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97
Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord (2007) 1.96
Survival and morbidity among two cohorts of extremely low birth weight neonates from a tertiary hospital in northern India. Indian Pediatr (2013) 1.95
Nested effects models for high-dimensional phenotyping screens. Bioinformatics (2007) 1.84
RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res (2004) 1.83
Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci (2004) 1.79
Finding disease specific alterations in the co-expression of genes. Bioinformatics (2004) 1.78
Non-transcriptional pathway features reconstructed from secondary effects of RNA interference. Bioinformatics (2005) 1.78
Psychosis pathways converge via D2high dopamine receptors. Synapse (2006) 1.78
Frequentist estimation of coalescence times from nucleotide sequence data using a tree-based partition. Genetics (2002) 1.75
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J Neurosci (2005) 1.74
Sequential elimination of major-effect contributors identifies additional quantitative trait loci conditioning high-temperature growth in yeast. Genetics (2008) 1.68
Neutrality condition and response law for nonlinear reaction-diffusion equations, with application to population genetics. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.67
Optimality approaches to describe characteristic fluvial patterns on landscapes. Philos Trans R Soc Lond B Biol Sci (2010) 1.66
Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int (2011) 1.64
Chemoresistance of glioblastoma cancer stem cells--much more complex than expected. Mol Cancer (2011) 1.64
A stochastic downhill search algorithm for estimating the local false discovery rate. IEEE/ACM Trans Comput Biol Bioinform (2006) 1.62
Guillain-Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol (2005) 1.62
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest (2008) 1.60
Proteogenomic analysis of Mycobacterium tuberculosis by high resolution mass spectrometry. Mol Cell Proteomics (2011) 1.58
A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem (2011) 1.58
Validation of microarray-based resequencing of 93 worldwide mitochondrial genomes. Hum Mutat (2009) 1.57
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol (2008) 1.56
Acid-induced activation of the urease promoters is mediated directly by the ArsRS two-component system of Helicobacter pylori. Infect Immun (2005) 1.56
Treadmill training for patients with Parkinson's disease. Cochrane Database Syst Rev (2010) 1.54
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol (2009) 1.54
TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain (2006) 1.54
Characterization of the ArsRS regulon of Helicobacter pylori, involved in acid adaptation. J Bacteriol (2006) 1.54
Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. N Engl J Med (2014) 1.53
Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage (2004) 1.52
Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells. Immunity (2012) 1.50
Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci U S A (2002) 1.49
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood (2008) 1.47
A randomised comparison of the effects of low-dose spinal or general anaesthesia on umbilical cord blood gases during caesarean delivery of growth-restricted foetuses with impaired Doppler flow. Eur J Anaesthesiol (2013) 1.47
Phosphorylation-independent activity of atypical response regulators of Helicobacter pylori. J Bacteriol (2005) 1.46
Y-chromosomal evidence of a pastoralist migration through Tanzania to southern Africa. Proc Natl Acad Sci U S A (2008) 1.46
Preoperative evaluation of carotid artery stenosis: comparison of contrast-enhanced MR angiography and duplex sonography with digital subtraction angiography. AJNR Am J Neuroradiol (2003) 1.46
Outcome of HIV exposed infants: experience of a regional pediatric center for HIV in North India. Indian J Pediatr (2011) 1.45
Predictors of mortality and major morbidities in extremely low birth weight neonates. Indian Pediatr (2013) 1.44
Transforming growth factor-beta1 is a negative modulator of adult neurogenesis. J Neuropathol Exp Neurol (2006) 1.44
Identification of target genes regulated by the two-component system HP166-HP165 of Helicobacter pylori. J Bacteriol (2002) 1.44
Predictors of mortality in neonates with meconium aspiration syndrome. Indian Pediatr (2014) 1.43
Intracranial hemorrhage: frequency, location, and risk factors identified in a TeleStroke network. Neuroreport (2015) 1.42
Neonatal trials need thousands, not hundreds, to change global practice. Acta Paediatr (2011) 1.41
A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol (2002) 1.41
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides (2007) 1.40
Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity. Circ Res (2012) 1.39